Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
During Miplyffa launch, Zevra CEO aims to foster EU-style Niemann Pick market in the US
By healthadmin
Zebra Therapeutics’ CEO believes the launch could change the treatment landscape for Niemann-Pick disease type…
For Roche, the Phase 3 failure in first-line breast cancer does not eliminate the blockbuster…
As the Ebola outbreak worsens, Merck is considering the use of the new coronavirus antiviral drug “Rajebrio”
By healthadmin
As governments and health authorities scramble to respond to the worsening Ebola outbreak in central…
More biopharmaceutical layoffs are occurring in New Jersey, this time in the latest round of…
Gilead’s Phase 3 trial of Libdelzi met its primary endpoint, demonstrating the drug’s ability to…
French pharmaceutical company Sanofi has launched an artificial intelligence agent to assist field personnel as…
Contraline and its male contraceptive candidate raked in $92.5 million as pushed into a ‘huge void’ in men’s health
By healthadmin
Amid changing attitudes toward family planning and contraception, and as the rise of telemedicine companies…
Eisai strengthens dietary guidance for Alzheimer’s disease patients and expands nutrition programs beyond cancer
By healthadmin
Eisai has partnered with CaringKind to expand its nutritional support efforts for Alzheimer’s disease and…
Combination strategies are rapidly redefining the treatment of HER2-positive solid tumors. In this video interview,…
Shionogi & Co.’s new coronavirus antiviral drug “Xocova” passes discussions with the FDA as a post-exposure prophylactic drug
By healthadmin
After failures in demonstrating the potential of the protease inhibitor ensitrevir as a treatment for…